Trial intelligence / Profile preview

Salivary Fluoride Clearance of MFP Dentifrices

NCT06735235Phase 1Completed

Sponsor
Procter & Gamble
Start
Jul 2021
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of sodium monofluorophosphate in dental caries (4 arms), sponsored by Procter & Gamble. Primary endpoint: Area Under the Curve for Fluoride Concentration at 30 months. Started Jul 2021; status: completed.

02

Drugs

sodium monofluorophosphate
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT06735235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06735235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call